Vuong Trieu - 26 May 2023 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role: CHAIRMAN AND CEO, Director, 10%+ Owner
Signature: /s/ Trieu, Vuong
Issuer symbol: OTLC
Transactions as of: 26 May 2023
Net transactions value: +$4,327
Form type: 4
Filing time: 31 May 2023, 09:39:02 UTC
Previous filing: 02 May 2023
Next filing: 16 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	OTLC	Common Stock	Purchase	$4,327	+126,888	+0.14%	$0.0341	91,044,217	26 May 2023	Direct
holding	OTLC	Common Stock						16,780,384	26 May 2023	By Autotelic, Inc.
holding	OTLC	Common Stock						6,872,529	26 May 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 126,888 shares of Oncotelic Therapeutics, Inc., in 5 tranches, in his individual capacity on May 26, 2023 from the open market at an average price of $0.0341.